Uncategorized

FDA bolsters bespoke therapy framework with new draft safety guidelines

FDA bolsters bespoke therapy framework with new draft safety guidelines

Published

on

The draft guidance supports the agency’s new pathway designed to speed up the development of custom gene therapies.​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version